Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Investigational New Drugs|June 12, 2021
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I studyAkira Kawai, Norifumi Naka, Akihiko Shimomura, et al.
Cancer Science|June 25, 2020
Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group studyHiroshi Urakawa, Akira Kawai, Takahiro Goto, et al.
Cancer Science|June 3, 2009
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcomaKazuhito Morioka, Chizu Tanikawa, Kensuke Ochi, et al.
International Journal of Clinical Oncology|July 8, 2015
Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcomaHidetatsu Outani, Kenichiro Hamada, Yoshinori Imura, et al.
Cancer Medicine|July 27, 2017
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcomaTakaaki Nakai, Yoshinori Imura, Hironari Tamiya, et al.
Pathology International|June 14, 2021
Giant cell tumor of bone - Analysis of 213 cases involving extra-craniofacial bonesEiichi Konishi, Hidetatsu Outani, Masayuki Mano, et al.
The Journal of Biological Chemistry|October 25, 2006
Expression of claudin7 is tightly associated with epithelial structures in synovial sarcomas and regulated by an Ets family transcription factor, ELF3Yoshiki Kohno, Takeshi Okamoto, Tatsuya Ishibe, et al.
Cancer Science|June 26, 2003
Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomasTakafumi Ueda, Yusuke Oji, Norifumi Naka, et al.
Scientific Reports|November 3, 2019
Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungsSho Nakai, Shutaro Yamada, Hidetatsu Outani, et al.
Scientific Reports|January 17, 2020
Author Correction: Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungsSho Nakai, Shutaro Yamada, Hidetatsu Outani, et al.
Pageof 10